Preclinical Development of ARTM-348 for Non-Alcoholic Steatohepatitis
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Artiam Bio Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Rangan Maitra
Fiscal Year
2022
Region
Research Triangle
Project Description:
Artiam Bio is developing small molecule drugs to treat non-alcoholic steatohepatitis (NASH), the most common liver disease in Western industralized countries. The company was awarded $250,000 in SRL funding to perform animal dose ranging studies and produce GMP material in preparation for their IND filing.